Concepedia

Author

Eric Zijlstra

Profil Institute for Metabolic ResearchORCID

Also Known As

E Zijlstra, E. Zijlstra, ERIC ZIJLSTRA, Eric Zijlstra

66

Publications

1.3K

Citations

19

H-Index

6

Concepts

All Affiliations

Profil Institute for Metabolic ResearchNovo Nordisk (Denmark)Eli Lilly (United States)Swansea University
EZ

About

Eric Zijlstra is an author at Profil Institute for Metabolic Research specializing in medicine, pharmacotherapy, and pharmacokinetics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

183

2

Diabetes

1

1

166

3

Pharmacology

1

1

17

4

Molecular Pharmacology

1

1

17

5

Pharmacokinetics

1

1

17

Eric Zijlstra

×

20

Publications

982

Citations

17

H-Index

YearCitations

Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, phase 2 trial

Inge B. Halberg, Karsten Lyby, Karsten Wassermann,

The Lancet Diabetes & Endocrinology

2019

166

Impact of injection speed and volume on perceived pain during subcutaneous injections into the abdomen and thigh: a single‐centre, randomized controlled trial

Tim Heise, Leszek Nosek, Sibylle Dellweg,

Diabetes Obesity and Metabolism

2014

105

Pharmacological properties of faster‐acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: A randomized, double‐blind, crossover trial

Tim Heise, Eric Zijlstra, Leszek Nosek,

Diabetes Obesity and Metabolism

2016

76

Impact of Injection Speed, Volume, and Site on Pain Sensation

Eric Zijlstra, Johannes Jahnke, Annelie Fischer,

Journal of Diabetes Science and Technology

2017

72

Pharmacokinetic and Pharmacodynamic Properties of Faster-Acting Insulin Aspart versus Insulin Aspart Across a Clinically Relevant Dose Range in Subjects with Type 1 Diabetes Mellitus

Tim Heise, Kirstine L. Stender-Petersen, Ulrike Hövelmann,

Clinical Pharmacokinetics

2016

68

Oral Insulin: A Comparison With Subcutaneous Regular Human Insulin in Patients With Type 2 Diabetes

Christoph Kapitza, Eric Zijlstra, Lutz Heinemann,

Diabetes Care

2010

66

Ultra rapid lispro lowers postprandial glucose and more closely matches normal physiological glucose response compared to other rapid insulin analogues: A phase 1 randomized, crossover study

Tim Heise, Helle Linnebjerg, David E. Coutant,

Diabetes Obesity and Metabolism

2020

63

Continuous glucose monitoring: quality of hypoglycaemia detection

Eric Zijlstra, Tim Heise, Leszek Nosek,

Diabetes Obesity and Metabolism

2012

59

Investigation of Pump Compatibility of Fast-Acting Insulin Aspart in Subjects With Type 1 Diabetes

Eric Zijlstra, Marek Demissie, Tina Graungaard,

Journal of Diabetes Science and Technology

2017

55

A Comparison of Pharmacokinetic and Pharmacodynamic Properties Between Faster-Acting Insulin Aspart and Insulin Aspart in Elderly Subjects with Type 1 Diabetes Mellitus

Tim Heise, Ulrike Hövelmann, Eric Zijlstra,

Drugs & Aging

2016

38

Page 1